bullish
Intuitive Surgical (ISRG US): Better-Than-Expected Q3 2022 Results; Raised Procedure Growth Guidance
174 Views19 Oct 2022 22:52
SUMMARY
- Despite challenging macroeconomic environment, Intuitive Surgical (ISRG US) reported stellar Q3 results, with revenue growing 11% y/y to $1.56 billion, mainly driven by da Vinci procedure growth of 20%.
- Q3 procedure growth reflected U.S. and OUS procedures growth of 18% and 24%, respectively. Management has raised 2022 da Vinci procedure growth guidance to 17–18% from 14.0–16.5% earlier.
- System placement improved 9% q/q to 305 placements, with system ASP remaining at $1.5 million, consistent with last quarter. As of 3Q22, installed base grew 13% y/y to 7,364 systems.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Intuitive Surgical (ISRG US): Fifth-Generation Device Approval Adds to Secular Growth Story15 Mar 2024
- Intuitive Surgical (ISRG US): Mixed Q3 Result; Encouraging Procedure Growth Is the Key Positive23 Oct 2023
- Intuitive Surgical (ISRG US): Robust Procedure Volume Drove 2Q23 Result; 2023 Outlook Raised22 Jul 2023
- Intuitive Surgical (ISRG US): Q2 2022 Results Missed Expectations; Raised Procedure Growth Guidance22 Jul 2022
- Intuitive Surgical (ISRG US): 1Q22 Review- Procedure Volume Growth Overshadowed by Macro Headwinds22 Apr 2022
- Intuitive Surgical (ISRG US): Global Leadership to Continue Amid Upcoming Competition13 Oct 2021
x